The Relationship Between Serum VCAM-1 and Alzheimer's Disease in Patients with Type 2 Diabetes Mellitus

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2020 Dec 10

PMID 33299334

Citations 1

Authors

Lingyun Zhang

Huawu Mao

Affiliations

Soon will be listed here.

Abstract

Background: Previous studies have reported that diabetes mellitus (DM) is a risk factor for Alzheimer's disease (AD). Vascular cell adhesion molecule-1 (VCAM-1) plays an important role in the pathological process of atherosclerosis. The aim was to elucidate the relationship between serum VCAM-1 and early AD in DM patients.

Methods: Serum samples for VCAM-1 were tested in 208 DM patients. All included DM patients were followed up for a median of 36 months prospectively. The prognostic value of serum VCAM-1 for predicting AD events was analyzed by using Cox proportional hazard.

Results: Serum VCAM-1 was independently associated with AD history after adjusting for related confounding factors in patients with DM at baseline by using the logistic regression analysis (OR=1.861; 95% CI, 1.435-2.539; =0.020). The Cox proportional hazard model suggested that VCAM-1 was a prognostic factor for AD events in the DM patients (HR=2.728; 95% CI, 1.785-5.439; <0.001). Stratified analysis showed that the significant association between AD event and serum VCAM-1 in DM patients was not affective by CVD history.

Conclusion: Our results showed that higher VCAM-1 levels were significantly related to a higher risk of AD events in DM patients. The serum biomarker might be beneficial to predict AD early. Serum VCAM-1 might be a good biochemical parameter for predicting AD in DM.

Citing Articles

Oral prodrug of a novel glutathione surrogate reverses metabolic dysregulation and attenuates neurodegenerative process in APP/PS1 mice.

Rao S, Imam-Fulani A, Xie W, Phillip S, Chennavajula K, Lind E bioRxiv. 2025; .

PMID: 39868172 PMC: 11761491. DOI: 10.1101/2025.01.15.633247.

Distinct response patterns of endothelial markers to the BNT162b2 mRNA COVID-19 booster vaccine are associated with the spike-specific IgG antibody production.

Castro-Robles B, Cimas F, Arias-Salazar L, Ontanon J, Lozano J, Lopez-Lopez S Front Immunol. 2025; 15():1471401.

PMID: 39835131 PMC: 11743620. DOI: 10.3389/fimmu.2024.1471401.

The Role of Inflammation, Oxidative Stress, Neuronal Damage, and Endothelial Dysfunction in the Neuropathology of Cognitive Complications in Diabetes: A Moderation and Mediation Analysis.

Sumbul-Sekerci B, Pasin O, Balkan E, Sekerci A Brain Behav. 2025; 15(1):e70225.

PMID: 39829127 PMC: 11743999. DOI: 10.1002/brb3.70225.

Advances in nanoprobes for molecular MRI of Alzheimer's disease.

Parekh P, Badachhape A, Tanifum E, Annapragada A, Ghaghada K Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(2):e1946.

PMID: 38426638 PMC: 10983770. DOI: 10.1002/wnan.1946.

References

Richard E, Schmand B, Eikelenboom P, Yang S, A Ligthart S, Moll van Charante E . Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects. Dement Geriatr Cogn Disord. 2012; 33(2-3):204-9. DOI: 10.1159/000338239. View

Wilkinson T, Donaldson G, Johnston S, Openshaw P, Wedzicha J . Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 173(8):871-6. DOI: 10.1164/rccm.200509-1489OC. View

Cho Y, Kim C, Ha T, Ahn H . Inhibition of STAT3 phosphorylation by sulforaphane reduces adhesion molecule expression in vascular endothelial cell. Can J Physiol Pharmacol. 2016; 94(11):1220-1226. DOI: 10.1139/cjpp-2015-0150. View

George L, Brightling C . Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease. Ther Adv Chronic Dis. 2016; 7(1):34-51. PMC: 4707428. DOI: 10.1177/2040622315609251. View

Petersen R . Do preclinical Alzheimer's disease criteria work?. Lancet Neurol. 2013; 12(10):933-5. DOI: 10.1016/S1474-4422(13)70217-5. View

Verdejo H, Roldan J, Garcia L, Del Campo A, Becerra E, Chiong M . Systemic vascular cell adhesion molecule-1 predicts the occurrence of post-operative atrial fibrillation. Int J Cardiol. 2010; 150(3):270-6. DOI: 10.1016/j.ijcard.2010.04.033. View

Roder C, Kupreichyk T, Gremer L, Schafer L, Pothula K, Ravelli R . Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-β fibrils. Nat Struct Mol Biol. 2020; 27(7):660-667. DOI: 10.1038/s41594-020-0442-4. View

. Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease [Retraction]. Am J Neurodegener Dis. 2016; 5(3):152. PMC: 4965615. View

Blankenberg S, Barbaux S, Tiret L . Adhesion molecules and atherosclerosis. Atherosclerosis. 2003; 170(2):191-203. DOI: 10.1016/s0021-9150(03)00097-2. View

10.

Hassing L, Grant M, Hofer S, Pedersen N, Nilsson S, Berg S . Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study. J Int Neuropsychol Soc. 2004; 10(4):599-607. DOI: 10.1017/S1355617704104165. View

11.

Chen M, Chang H, Juang S, Yip H, Wu C, Yu T . Percutaneous transluminal mitral valvuloplasty reduces circulating vascular cell adhesion molecule-1 in rheumatic mitral stenosis. Chest. 2004; 125(4):1213-7. DOI: 10.1378/chest.125.4.1213. View

12.

Kaufmann B, Sanders J, Davis C, Xie A, Aldred P, Sarembock I . Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation. 2007; 116(3):276-84. DOI: 10.1161/CIRCULATIONAHA.106.684738. View

13.

Hammwohner M, Ittenson A, Dierkes J, Bukowska A, Klein H, Lendeckel U . Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation. Exp Biol Med (Maywood). 2007; 232(4):581-9. View

14.

Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M . Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet. 2001; 358(9286):971-6. DOI: 10.1016/S0140-6736(01)06104-9. View

15.

Hatanaka H, Hanyu H, Fukasawa R, Hirao K, Shimizu S, Kanetaka H . Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients. Geriatr Gerontol Int. 2015; 15 Suppl 1:53-8. DOI: 10.1111/ggi.12659. View

16.

Hope S, Meredith I . Cellular adhesion molecules and cardiovascular disease. Part I. Their expression and role in atherogenesis. Intern Med J. 2003; 33(8):380-6. DOI: 10.1046/j.1444-0903.2003.00378.x. View

17.

Verdile G, Keane K, Cruzat V, Medic S, Sabale M, Rowles J . Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease. Mediators Inflamm. 2015; 2015:105828. PMC: 4674598. DOI: 10.1155/2015/105828. View

18.

Orndorff R, Hong N, Yu K, Feinstein S, Zern B, Fisher A . NOX2 in lung inflammation: quantum dot based in situ imaging of NOX2-mediated expression of vascular cell adhesion molecule-1. Am J Physiol Lung Cell Mol Physiol. 2013; 306(3):L260-8. PMC: 3920203. DOI: 10.1152/ajplung.00278.2013. View

19.

van Elderen S, de Roos A, de Craen A, Westendorp R, Blauw G, Jukema J . Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology. 2010; 75(11):997-1002. DOI: 10.1212/WNL.0b013e3181f25f06. View

20.

Valente T, Gella A, Fernandez-Busquets X, Unzeta M, Durany N . Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus. Neurobiol Dis. 2009; 37(1):67-76. DOI: 10.1016/j.nbd.2009.09.008. View